Literature DB >> 8862617

Fecal lactoferrin screening assay for inflammatory bacterial diarrhea.

I Nachamkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862617      PMCID: PMC229250          DOI: 10.1128/jcm.34.9.2337-2338.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  7 in total

1.  The use and abuse of routine stool microbiology: a College of American Pathologists Q-probes study of 601 institutions.

Authors:  P Valenstein; M Pfaller; M Yungbluth
Journal:  Arch Pathol Lab Med       Date:  1996-02       Impact factor: 5.534

2.  Role of stool screening tests in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens.

Authors:  R P Silletti; G Lee; E Ailey
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea.

Authors:  S W Choi; C H Park; T M Silva; E I Zaenker; R L Guerrant
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

4.  Inappropriate testing for diarrheal diseases in the hospital.

Authors:  D L Siegel; P H Edelstein; I Nachamkin
Journal:  JAMA       Date:  1990-02-16       Impact factor: 56.272

5.  Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease.

Authors:  W H Yong; A R Mattia; M J Ferraro
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

6.  Value of examination for fecal leukocytes in the early diagnosis of shigellosis.

Authors:  O M Korzeniowski; F A Barada; J D Rouse; R L Guerrant
Journal:  Am J Trop Med Hyg       Date:  1979-11       Impact factor: 2.345

7.  Clostridium difficile colitis: an efficient clinical approach to diagnosis.

Authors:  Y C Manabe; J M Vinetz; R D Moore; C Merz; P Charache; J G Bartlett
Journal:  Ann Intern Med       Date:  1995-12-01       Impact factor: 25.391

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.